Abstract:Introduction: Spatially restricted gene expression circumvents the gene expression and gene vector problem by enabling localized amplification. The objective of this study is to construct a spatially restricted gene expression for liver cancer therapy based upon the MFHabsorbing properties of PEI- Mn0.5zn0.5Fe2o4, gene therapy and radiation. Methods: Mn0.5zn0.5Fe2O4 (MZF) magnetic nanoparticles were prepared by an improved chemical co-precipitation method, modified by polyethylene imine (PEI), and then the structure, modification characters, biocompatibility, temperature rise and control ability and binding efficiency of the plasmid were characterized. Then, the dual-promoter plasmid PCDNA3.1-EGR1HSP70-HSVTK was constructed. The recombinant vectors were identified by enzyme digestion analysis and DNA sequencing. The TK gene expression level was detected by realtime-PCR assay in HEK293 cells. Also, the HSV-TK gene expression was detected in SMMC7721 cells with the help of PEI-Mn0.5Zn0.5Fe2O4. In vitro anti-tumor experiment, MTT assay and flow cytometry were used to evaluate the therapeutic effects of the cultured SMMC7721 cells treated by different ways. In vivo anti-tumor experiment, the xenografted mice were treated by different ways for three times to detect the antitumor effect. Results: The Mn0.5Zn0.5Fe2O4 magnetic nanoparticles could be successfully prepared through improved co-precipitation process and showed good biocompatibility. And PEI had been coated on MZF complex. The modified PEI-MZF presented favorable dispensability, responsibility to magnetism, good loading capability and transfect capability. Also, pCDNA3.1-Egr1-Hsp70HSVTK plasmid had been constructed successfully and could be induced by heat and irradiation. It would be used for further target gene therapy research. The antitumor results in vitro showed: The therapeutic effects of nanosized PEI-MZF-HSV-TK complex could significantly inhibit the proliferation of cultured liver cancer cells (SMC7721), induce cell apoptosis and had a prominent cell cycle disturbance in the S phase in vitro. The results in vivo showed: The combined therapy induced by PEI-MZF-HSV-TK could inhabit the growth of hepatocellular carcinoma xenografts by killing and inhabiting the proliferation of the tumor cells. Conclusion: The novel site-directed heat/radiation-inducible expression system based upon the hyperthermia (by MFH) and radiation possessed superior antitumor effect in vivo and in vitro.

mdr1 promoter-driven tumor necrosis factor-α expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors

Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.

Systemic TNFα gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer

Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy

Experimental Studies on Radiation-Inducible Human TNF Gene Therapy for Cancer

Preliminary Study on Conquering Multidrug Resistance with Exogenous TNF-α Gene Therapy

Antitumor Effects of Cytosine Deaminase and Thymidine Kinase Fusion Suicide Gene under the Control of Mdr1 Promoter in Mdr1 Positive Leukemia Cells

Spatiotemporally Controllable Diphtheria Toxin Expression Using a Light-Switchable Transgene System Combining Multifunctional Nanoparticle Delivery System for Targeted Melanoma Therapy

Inhibitory Effect and Mechanism of Human Tumor Necrosis Factor-α Gene Transfected into Human Hepatoma Transplantation Tumor by LipofectamineTM 2000 in Nude Mice

A Novel Synthetic Htert-Mini-cmv Chimera Promoter-Driven Tumor-Selective and High-Efficiency Expression of Transgene for Systemic Cancer Gene Therapy

The Targeted Gene (KDRP-CD/TK) Therapy of Breast Cancer Mediated by SonoVue and Ultrasound Irradiation in Vitro

Egr1/HSP70 Promoter-Driven Activation of Gene Expression for Synergistic Anti-Hepatoma Using PEI-MZF Nanoparticles and Radiation

Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes

Complete Regression of Established Murine Hepatocellular Carcinoma by in Vivo Tumor Necrosis Factor Alpha Gene Transfer

Suppression of Teratocarcinoma Growth by Soluble Trail Gene Expression Driven by the Progression-Elevated Gene-3 Promoter

A Safe, Effective in Vivo Gene Therapy for Melanoma Using Tyrosinase Promoter-Driven Cytosine Deaminase Gene

Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy

The Progress of Tumor Gene-Radiotherapy Induced by Egr-1 Promoter

Enhanced Suicide Gene Therapy Using A Tumor-Specific Promoter in Combination with Cisplatin

Study on the Inhibition of Drug-Resistant Human Breast Cancer Cells with Exogenous Tumor Necrosis Faclor-Α Gene Therapy

Development of a Multi-Target Peptide for Potentiating Chemotherapy by Modulating Tumor Microenvironment.